This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bulls Hope for IMAX Blockbuster

By Chris McKhann , analyst at OptionMonster

NEW YORK -- IMAX (IMAX) may be breaking out of its recent range, and traders are buying into the digital-theater company ahead of its earnings report on Thursday.

More than 10,300 December 24 calls were purchased on Friday, led by 9,300 that traded at the same second for 65 cents, according to OptionMonster's real-time tracking systems. The volume dwarfed open interest in the strike, which was just 476 contracts at the start of the session, so this was fresh buying.

IMAX rose 1.44% to close at $21.85, breaking above its 100-day moving average. The stock had been trading sideways for about two months until popping on Thursday after Credit Suisse initiated coverage of the name with a price target of $28.

Friday's call-buyers are looking for the stock to gain roughly 13% by expiration. The premiums on those options could rise with any rally before then, allowing the traders to sell the calls at a profit earlier. However, if the options are not above the $24 strike price by mid-December, they will expire worthless.

Total option volume in the name was more than 14 times its daily average. Only 582 puts changed hands in the entire session, a reflection of the bullish sentiment.

McKhann has no positions in IMAX.

This commentary comes from an independent investor or market observer as part of TheStreet guest contributor program. The views expressed are those of the author and do not necessarily represent the views of TheStreet or its management.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $132.54 0.00%
FB $80.54 0.00%
GOOG $540.11 0.00%
TSLA $247.73 0.00%
YHOO $43.48 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports